110 related articles for article (PubMed ID: 27314088)
1. FOXC1-induced Gli2 activation: A non-canonical pathway contributing to stemness and anti-Hedgehog resistance in basal-like breast cancer.
Han B; Qu Y; Yu-Rice Y; Johnson J; Cui X
Mol Cell Oncol; 2016 May; 3(3):e1131668. PubMed ID: 27314088
[TBL] [Abstract][Full Text] [Related]
2. FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer.
Han B; Qu Y; Jin Y; Yu Y; Deng N; Wawrowsky K; Zhang X; Li N; Bose S; Wang Q; Sakkiah S; Abrol R; Jensen TW; Berman BP; Tanaka H; Johnson J; Gao B; Hao J; Liu Z; Buttyan R; Ray PS; Hung MC; Giuliano AE; Cui X
Cell Rep; 2015 Nov; 13(5):1046-58. PubMed ID: 26565916
[TBL] [Abstract][Full Text] [Related]
3. Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.
Chung S; Jin Y; Han B; Qu Y; Gao B; Giuliano AE; Cui X
Cell Commun Signal; 2017 Jun; 15(1):22. PubMed ID: 28629477
[TBL] [Abstract][Full Text] [Related]
4. FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling.
Wang J; Ray PS; Sim MS; Zhou XZ; Lu KP; Lee AV; Lin X; Bagaria SP; Giuliano AE; Cui X
Oncogene; 2012 Nov; 31(45):4798-802. PubMed ID: 22249250
[TBL] [Abstract][Full Text] [Related]
5. Basal-like breast cancer defined by FOXC1 expression offers superior prognostic value: a retrospective immunohistochemical study.
Ray PS; Bagaria SP; Wang J; Shamonki JM; Ye X; Sim MS; Steen S; Qu Y; Cui X; Giuliano AE
Ann Surg Oncol; 2011 Dec; 18(13):3839-47. PubMed ID: 21424368
[TBL] [Abstract][Full Text] [Related]
6. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
[TBL] [Abstract][Full Text] [Related]
7. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of FOXC1 as a therapeutic target for basal-like breast cancer.
Mott L; Su K; Pack DW
Cancer Gene Ther; 2018 May; 25(3-4):84-91. PubMed ID: 29511313
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis of Basal-Like Breast Cancer Using a FOXC1-Based Assay.
Jensen TW; Ray T; Wang J; Li X; Naritoku WY; Han B; Bellafiore F; Bagaria SP; Qu A; Cui X; Taylor CR; Ray PS
J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26041837
[TBL] [Abstract][Full Text] [Related]
10. Retracted Article: FOXC1 silencing promotes A549 cell apoptosis through inhibiting the PI3K/AKT/hedgehog/Gli2 signaling pathway.
Wang P; Ma H; Li Y; Chen D; Li X; Gao X
RSC Adv; 2018 Sep; 8(59):33786-33793. PubMed ID: 35548824
[TBL] [Abstract][Full Text] [Related]
11. Research progress on the forkhead box C1.
Wang J; Li W; Zheng X; Pang X; Du G
Oncotarget; 2018 Feb; 9(15):12471-12478. PubMed ID: 29552326
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor Foxc1 is necessary for Ihh-Gli2-regulated endochondral ossification.
Yoshida M; Hata K; Takashima R; Ono K; Nakamura E; Takahata Y; Murakami T; Iseki S; Takano-Yamamoto T; Nishimura R; Yoneda T
Nat Commun; 2015 Mar; 6():6653. PubMed ID: 25808752
[TBL] [Abstract][Full Text] [Related]
13. Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease.
Grzelak CA; Sigglekow ND; Tirnitz-Parker JE; Hamson EJ; Warren A; Maneck B; Chen J; Patkunanathan B; Boland J; Cheng R; Shackel NA; Seth D; Bowen DG; Martelotto LG; Watkins DN; McCaughan GW
PLoS One; 2017; 12(2):e0171480. PubMed ID: 28187190
[TBL] [Abstract][Full Text] [Related]
14. The potential pathway of FOXC1 high expression in regulating the proliferation, migration, cell cycle and epithelialmesenchymal transition of basal-like breast cancer and in vivo imaging.
Zuo H; Yang Q
J BUON; 2018; 23(3):720-728. PubMed ID: 30003742
[TBL] [Abstract][Full Text] [Related]
15. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
[TBL] [Abstract][Full Text] [Related]
16. FOXC1: an emerging marker and therapeutic target for cancer.
Han B; Bhowmick N; Qu Y; Chung S; Giuliano AE; Cui X
Oncogene; 2017 Jul; 36(28):3957-3963. PubMed ID: 28288141
[TBL] [Abstract][Full Text] [Related]
17. The Hedgehog Signaling Pathway: A Viable Target in Breast Cancer?
Bhateja P; Cherian M; Majumder S; Ramaswamy B
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31394751
[TBL] [Abstract][Full Text] [Related]
18. The role and the potential regulatory pathways of high expression of forkhead box C1 in promoting tumor growth and metastasis of basal-like breast cancer.
Zuo HD; Wu Yao W
J BUON; 2016; 21(4):818-825. PubMed ID: 27685901
[TBL] [Abstract][Full Text] [Related]
19. FOXC1, the new player in the cancer sandbox.
Elian FA; Yan E; Walter MA
Oncotarget; 2018 Jan; 9(8):8165-8178. PubMed ID: 29487724
[TBL] [Abstract][Full Text] [Related]
20. FOXC1 induces cancer stem cell-like properties through upregulation of beta-catenin in NSCLC.
Cao S; Wang Z; Gao X; He W; Cai Y; Chen H; Xu R
J Exp Clin Cancer Res; 2018 Sep; 37(1):220. PubMed ID: 30189871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
